# Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

> **NCT05040659** · — · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Anosmia
- Asymptomatic COVID-19
- COVID-19 Respiratory Infection
- Influenza
- Healthy
- PASC Post Acute Sequelae of COVID 19

## Interventions

- **DEVICE:** AROMHA Longitudinal Smell Test

## Key facts

- **NCT ID:** NCT05040659
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-14
- **Primary completion:** 2024-12-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05040659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05040659, "Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05040659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*